{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:46:35Z","timestamp":1790837195060,"version":"4.1.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.bbcan.2003.09.002","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T21:48:52Z","timestamp":1072129732000},"page":"79-94","source":"Crossref","is-referenced-by-count":22,"title":["Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?"],"prefix":"10.1016","volume":"1654","author":[{"given":"Aernout","family":"Luttun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Autiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tjwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Carmeliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2003.09.002_BIB1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(01)65002-5","article-title":"The growth of malignant disease in man and the lower animals with special reference to the vascular system","volume":"ii","author":"Goldman","year":"1907","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB3","first-page":"111","article-title":"Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique","volume":"41","author":"Greenblatt","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB4","first-page":"1329","article-title":"Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy","volume":"41","author":"Ehrmann","year":"1968","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB5","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB7","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1084\/jem.194.6.F37","article-title":"Lymphatic vessels as targets of tumor therapy?","volume":"194","author":"Karpanen","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB8","first-page":"462","article-title":"Lymphangiogenesis and tumor metastasis: myth or reality?","volume":"7","author":"Pepper","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1050-1738(01)00152-9","article-title":"Vascular progenitors: from biology to treatment","volume":"12","author":"Luttun","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrc925","article-title":"Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?","volume":"2","author":"Rafii","year":"2002","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/152581602753658385","article-title":"Endothelial progenitor cells for vascular regeneration","volume":"11","author":"Asahara","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(00)81511-1","article-title":"Prox1 function is required for the development of the murine lymphatic system","volume":"98","author":"Wigle","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/dvdy.1187","article-title":"Endogenous origin of the lymphatics in the avian chorioallantoic membrane","volume":"222","author":"Papoutsi","year":"2001","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB15","first-page":"3683","article-title":"Fractals and cancer","volume":"60","author":"Baish","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm0297-177","article-title":"Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation","volume":"3","author":"Helmlinger","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2002.37265","article-title":"Tumor angiogenesis and accessibility: role of vascular endothelial growth factor","volume":"29","author":"Jain","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness","volume":"156","author":"Hashizume","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB19","first-page":"5476","article-title":"Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy","volume":"62","author":"Pietras","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","article-title":"Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors","volume":"160","author":"Morikawa","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","article-title":"Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal","volume":"103","author":"Benjamin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","article-title":"A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF","volume":"125","author":"Benjamin","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors","volume":"111","author":"Bergers","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","article-title":"Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model","volume":"279","author":"Arap","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB25","first-page":"2641","article-title":"Determinants of tumor blood flow: a review","volume":"48","author":"Jain","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB26","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.97.26.14608","article-title":"Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood","volume":"97","author":"Chang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1535-6108(02)00051-X","article-title":"Molecular mechanisms of lymphangiogenesis in health and disease","volume":"1","author":"Alitalo","year":"2002","journal-title":"Cancer Cells"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB28","first-page":"4324","article-title":"Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation","volume":"60","author":"Leu","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","author":"Jain","year":"1994","journal-title":"Sci. Am."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(97)00027-6","article-title":"Delivery of molecular and cellular medicine to solid tumors","volume":"26","author":"Jain","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0272-6386(01)80019-6","article-title":"Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease","volume":"37","author":"Kang","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-230X(08)60862-3","article-title":"How tumors become angiogenic","volume":"69","author":"Bouck","year":"1996","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/carcin\/21.3.505","article-title":"Tumor angiogenesis: past, present and the near future","volume":"21","author":"Kerbel","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/44304","article-title":"Developmental biology. Controlling the cellular brakes","volume":"401","author":"Carmeliet","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0092-8674(00)81731-6","article-title":"Tumor induction of VEGF promoter activity in stromal cells","volume":"94","author":"Fukumura","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G","article-title":"Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis","volume":"193","author":"Achen","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9440(10)65550-2","article-title":"Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors","volume":"153","author":"Salven","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","article-title":"Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis","volume":"7","author":"Skobe","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis","volume":"20","author":"Mandriota","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB42","first-page":"1786","article-title":"Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth","volume":"61","author":"Karpanen","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB43","first-page":"1388","article-title":"Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies","volume":"60","author":"Eberhard","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/hc0102.101437","article-title":"Analysis of mural cell recruitment to tumor vessels","volume":"105","author":"Abramsson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1567-5769(02)00064-4","article-title":"Tumor-associated macrophages: a molecular perspective","volume":"2","author":"Sica","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm871","article-title":"Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells","volume":"9","author":"De Palma","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/152581602753448540","article-title":"Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells","volume":"11","author":"Schmeisser","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB49","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.0000058702.69484.A0","article-title":"Peripheral blood \u201cendothelial progenitor cells\u201d are derived from monocyte\/macrophages and secrete angiogenic growth factors","volume":"107","author":"Rehman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nm819","article-title":"VEGF: a modifier of the del22q11 (DiGeorge) syndrome?","volume":"9","author":"Stalmans","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB55","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1242\/dev.125.19.3905","article-title":"VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus","volume":"125","author":"Cleaver","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0925-4773(01)00468-3","article-title":"The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development","volume":"108","author":"Liang","year":"2001","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB57","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5","article-title":"Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant","volume":"17","author":"Nasevicius","year":"2000","journal-title":"Yeast"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/8379","article-title":"Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188","volume":"5","author":"Carmeliet","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI0214362","article-title":"Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms","volume":"109","author":"Stalmans","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0925-4773(01)00601-3","article-title":"Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188","volume":"111","author":"Maes","year":"2002","journal-title":"Mech. Dev."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB61","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.ASN.0000013925.19218.7B","article-title":"Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice","volume":"13","author":"Mattot","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB62","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1242\/dev.127.7.1445","article-title":"Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state","volume":"127","author":"Haigh","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB64","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI18015","article-title":"Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?","volume":"111","author":"Luttun","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/labinvest.3780013","article-title":"Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor\/vascular endothelial growth factor","volume":"80","author":"Pettersson","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB66","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.CIR.102.8.898","article-title":"VEGF gene delivery to myocardium: deleterious effects of unregulated expression","volume":"102","author":"Lee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB67","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/emboj\/21.8.1939","article-title":"Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy","volume":"21","author":"Dor","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB68","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1126\/science.286.5449.2511","article-title":"Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1","volume":"286","author":"Thurston","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB69","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB70","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB71","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001622-200211000-00010","article-title":"Vascular endothelial growth factor as a target opportunity in hematological malignancies","volume":"14","author":"Bellamy","year":"2002","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/scientificamerican1201-38","article-title":"Vessels of death or life","volume":"285","author":"Jain","year":"2001","journal-title":"Sci. Am."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(02)00208-8","article-title":"Vaccination against tumor neovascularization: promise and reality","volume":"2","author":"Rafii","year":"2002","journal-title":"Cancer Cells"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB75","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB76","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB78","first-page":"4593","article-title":"Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders","volume":"57","author":"Presta","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB79","first-page":"5565","article-title":"Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions","volume":"60","author":"Lee","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB80","first-page":"5209","article-title":"Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors","volume":"59","author":"Prewett","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB81","first-page":"3540","article-title":"Flk-1 as a target for tumor growth inhibition","volume":"56","author":"Strawn","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB82","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1073\/pnas.191117498","article-title":"Inhibition of both paracrine and autocrine VEGF\/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias","volume":"98","author":"Dias","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB83","first-page":"99","article-title":"SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types","volume":"59","author":"Fong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB84","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB85","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB87","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1167\/iovs.02-0276","article-title":"Potential role of the angiopoietin\/tie2 system in ischemia-induced retinal neovascularization","volume":"44","author":"Takagi","year":"2003","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB88","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.282.5388.468","article-title":"Increased vascularization in mice overexpressing angiopoietin-1","volume":"282","author":"Suri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB89","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/excr.2002.5597","article-title":"Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice","volume":"279","author":"Shim","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB90","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.193.9.1005","article-title":"Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells","volume":"193","author":"Hattori","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB91","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1073\/pnas.122109599","article-title":"Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF)","volume":"99","author":"Visconti","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB92","first-page":"1255","article-title":"The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer","volume":"61","author":"Ahmad","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB93","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB94","doi-asserted-by":"crossref","first-page":"26516","DOI":"10.1074\/jbc.M100282200","article-title":"Direct cell adhesion to the angiopoietins mediated by integrins","volume":"276","author":"Carlson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB95","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","article-title":"Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1","volume":"3","author":"Gale","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB96","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcp.10128","article-title":"Angiopoietin-2 plays an important role in retinal angiogenesis","volume":"192","author":"Hackett","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB97","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0037-1616232","article-title":"Extracellular proteolysis and angiogenesis","volume":"86","author":"Pepper","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00041552-200205000-00005","article-title":"Matrix metalloproteinases and angiogenesis","volume":"11","author":"Jackson","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB99","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11883-000-0079-z","article-title":"The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies","volume":"2","author":"Luttun","year":"2000","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB100","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1038\/sj.onc.1205745","article-title":"Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis","volume":"21","author":"Berchem","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0014-5793(99)00897-2","article-title":"Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases","volume":"455","author":"Kostoulas","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000064027","article-title":"Expanded human tissue kallikrein family\u2014a novel panel of cancer biomarkers","volume":"23","author":"Yousef","year":"2002","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB103","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2002-01-0185","article-title":"Kallistatin is a new inhibitor of angiogenesis and tumor growth","volume":"100","author":"Miao","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB104","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1096\/fj.01-0552com","article-title":"The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent","volume":"16","author":"Devy","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB106","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1096\/fj.00-0393com","article-title":"Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization","volume":"15","author":"Lambert","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB107","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm0898-923","article-title":"Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization","volume":"4","author":"Bajou","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB108","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/13459","article-title":"Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure","volume":"5","author":"Heymans","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB109","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.152.4.777","article-title":"The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies","volume":"152","author":"Bajou","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB110","first-page":"1048","article-title":"Reduced angiogenesis and tumor progression in gelatinase A-deficient mice","volume":"58","author":"Itoh","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB111","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1096\/fj.01-0790com","article-title":"MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression","volume":"16","author":"Sounni","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB112","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000065305","article-title":"Coagulation, fibrinolysis and angiogenesis: new insights from knockout mice","volume":"10","author":"Brodsky","year":"2002","journal-title":"Exp. Nephrol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB113","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2002-20563","article-title":"Platelets and cancer: implications for antiangiogenic therapy","volume":"28","author":"Trikha","year":"2002","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB114","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1126\/science.1064981","article-title":"Biomedicine. Clotting factors build blood vessels","volume":"293","author":"Carmeliet","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00062752-200209000-00003","article-title":"Tissue factor and angiogenesis in cancer","volume":"9","author":"Fernandez","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB116","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood.V91.8.2698.2698_2698_2703","article-title":"Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII","volume":"91","author":"Ollivier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB117","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1073\/pnas.96.15.8663","article-title":"Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor","volume":"96","author":"Abe","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB118","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI117451","article-title":"Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice","volume":"94","author":"Zhang","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02981930","article-title":"The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer","volume":"73","author":"Rickles","year":"2001","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(00)81010-7","article-title":"Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis","volume":"98","author":"Carmeliet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB121","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood.V100.3.905","article-title":"A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability","volume":"100","author":"Corada","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB122","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.96.17.9815","article-title":"Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo","volume":"96","author":"Corada","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB123","doi-asserted-by":"crossref","first-page":"C1181","DOI":"10.1152\/ajpcell.00524.2001","article-title":"Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration","volume":"282","author":"Cao","year":"2002","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB124","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0002-9440(10)64418-5","article-title":"Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis","volume":"161","author":"Hangai","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nm0902-918","article-title":"A reevaluation of integrins as regulators of angiogenesis","volume":"8","author":"Hynes","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB127","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64363-5","article-title":"The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis","volume":"160","author":"Senger","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0102-27","article-title":"Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins","volume":"8","author":"Reynolds","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB131","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.090065597","article-title":"Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases","volume":"97","author":"Sauter","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB132","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.95.11.6367","article-title":"Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest","volume":"95","author":"Griscelli","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB133","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1381612033391342","article-title":"Thrombospondins as anti-angiogenic therapeutic agents","volume":"9","author":"Vailhe","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB134","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9440(10)65140-1","article-title":"Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas","volume":"155","author":"Streit","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB135","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1073\/pnas.96.8.4449","article-title":"Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity","volume":"96","author":"Kyriakides","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB136","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0002-9440(10)62512-6","article-title":"Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice","volume":"159","author":"Kyriakides","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB137","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB138","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-1759(02)00420-9","article-title":"Analysis of the role of chemokines in angiogenesis","volume":"273","author":"Bernardini","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"Suppl. 15","key":"10.1016\/j.bbcan.2003.09.002_BIB139","first-page":"93","article-title":"Angiogenic switch as a molecular target of malignant tumors","volume":"38","author":"Tanaka","year":"2003","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ijc.10336","article-title":"Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer","volume":"99","author":"Shirakawa","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB141","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4914(02)02367-5","article-title":"Tales of the cryptic: unveiling more angiogenesis inhibitors","volume":"8","author":"D'Amore","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB142","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB143","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/scdb.2001.0287","article-title":"Oxygen sensors and angiogenesis","volume":"13","author":"Maxwell","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB144","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1050-1738(97)00091-1","article-title":"Ischemia-driven angiogenesis","volume":"7","author":"Dor","year":"1997","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB146","first-page":"6248","article-title":"Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha\u2013>hypoxia response element\u2013> VEGF cascade differentially regulates vascular response and growth rate in tumors","volume":"60","author":"Tsuzuki","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB147","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB148","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB149","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1 alpha is required for solid tumor formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB150","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0002-9440(10)64083-7","article-title":"Heterogeneous vascular dependence of tumor cell populations","volume":"158","author":"Yu","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB151","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cells"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB152","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/44334","article-title":"Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts","volume":"401","author":"Lyden","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB153","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15216540252774784","article-title":"VEGF receptor signaling and endothelial function","volume":"52","author":"Kliche","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB154","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1247\/csf.26.25","article-title":"Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis","volume":"26","author":"Shibuya","year":"2001","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm1102-1329b","article-title":"Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice","volume":"8","author":"Compernolle","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB156","doi-asserted-by":"crossref","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","article-title":"Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure","volume":"283","author":"Le Cras","year":"2002","journal-title":"Am. J. Physiol., Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB157","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independent endothelial protection of liver: role of VEGFR-1","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB158","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/01.HYP.0000018588.56950.7A","article-title":"KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF","volume":"39","author":"Li","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB159","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor","volume":"88","author":"Maglione","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(93)90127-C","article-title":"A structural superfamily of growth factors containing a cystine knot motif","volume":"73","author":"McDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB161","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnen\/61.4.339","article-title":"Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling","volume":"61","author":"Beck","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB162","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1050-1738(01)00164-5","article-title":"Role of placenta growth factor in cardiovascular health","volume":"12","author":"Iyer","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB163","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB164","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<66::AID-PATH390>3.0.CO;2-X","article-title":"Expression and localization of placenta growth factor and PlGF receptors in human meningiomas","volume":"189","author":"Donnini","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1747.2000.00199.x","article-title":"Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor","volume":"115","author":"Lacal","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB166","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB167","first-page":"213","article-title":"Flt-1 but not KDR\/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor","volume":"7","author":"Sawano","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB168","first-page":"517","article-title":"Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic","volume":"76","author":"Ziche","year":"1997","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB169","first-page":"31","article-title":"Structure, expression and receptor-binding properties of placental growth factor (PlGF)","volume":"237","author":"Persico","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB170","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB171","doi-asserted-by":"crossref","first-page":"C176","DOI":"10.1152\/ajpcell.1999.276.1.C176","article-title":"KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells","volume":"276","author":"Cunningham","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB172","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB173","first-page":"519","article-title":"Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family","volume":"5","author":"Shibuya","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB174","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jcb.240540107","article-title":"Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells","volume":"54","author":"Barleon","year":"1994","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jcp.1121","article-title":"Expression of vascular endothelial growth factor receptors in smooth muscle cells","volume":"188","author":"Ishida","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB176","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","article-title":"Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1","volume":"87","author":"Barleon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB177","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB178","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/hupa.2001.21139","article-title":"Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density","volume":"32","author":"Nagura","year":"2001","journal-title":"Human Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB179","first-page":"1573","article-title":"Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells","volume":"79","author":"Herold-Mende","year":"1999","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB180","first-page":"99","article-title":"Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro","volume":"17","author":"Volm","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB181","first-page":"2811","article-title":"Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma","volume":"17","author":"Takanami","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB182","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-5347(05)67414-9","article-title":"Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues","volume":"164","author":"Hahn","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB183","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H","article-title":"Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops","volume":"184","author":"de Jong","year":"1998","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB184","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.0.CO;2-E","article-title":"Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa","volume":"86","author":"Andre","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB185","first-page":"14","article-title":"Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis","volume":"14","author":"Inoki","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB186","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1013329832067","article-title":"Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft","volume":"55","author":"Stefanik","year":"2001","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB187","first-page":"5019","article-title":"The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787\/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment","volume":"62","author":"Lin","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB188","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.56.2.107","article-title":"Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma","volume":"56","author":"Ghanem","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB189","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants","volume":"276","author":"Gille","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB190","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1074\/jbc.273.35.22272","article-title":"Neuropilin-1 is a placenta growth factor-2 receptor","volume":"273","author":"Migdal","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB191","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1749-6632.2000.tb06314.x","article-title":"Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction","volume":"902","author":"Sato","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB192","first-page":"135","article-title":"A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF","volume":"10","author":"Seetharam","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB193","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.onc.1201545","article-title":"Placental growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt-1","volume":"16","author":"Landgren","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB194","doi-asserted-by":"crossref","first-page":"26969","DOI":"10.1074\/jbc.M103213200","article-title":"Vascular permeability factor (VPF)\/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF\/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways","volume":"276","author":"Zeng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB195","doi-asserted-by":"crossref","first-page":"46791","DOI":"10.1074\/jbc.M206133200","article-title":"KDR stimulates endothelial cell migration through heterotrimeric G protein Gq\/11-mediated activation of a small GTPase RhoA","volume":"277","author":"Zeng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB196","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/emboj\/19.15.4064","article-title":"A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3\u2032-kinase activation and endothelial cell migration","volume":"19","author":"Gille","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB197","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/01.ATV.0000038995.31179.24","article-title":"Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors","volume":"22","author":"Yang","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB198","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1074\/jbc.M000528200","article-title":"Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells","volume":"275","author":"Rahimi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB199","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/sj.onc.1203533","article-title":"Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells","volume":"19","author":"Kanno","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","article-title":"Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium","volume":"376","author":"Fong","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB201","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","article-title":"Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice","volume":"95","author":"Hiratsuka","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB202","doi-asserted-by":"crossref","first-page":"C1358","DOI":"10.1152\/ajpcell.2001.280.6.C1358","article-title":"Role of vascular endothelial growth factor in regulation of physiological angiogenesis","volume":"280","author":"Ferrara","year":"2001","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB203","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB204","first-page":"2696","article-title":"Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1","volume":"61","author":"Green","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB205","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","article-title":"Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans","volume":"97","author":"Sawano","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB206","first-page":"1207","article-title":"Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis","volume":"61","author":"Hiratsuka","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB207","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1242\/jcs.115.12.2559","article-title":"Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability","volume":"115","author":"Odorisio","year":"2002","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0008-6363(02)00326-7","article-title":"Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1\/VEGF-receptor-1","volume":"55","author":"Parenti","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB209","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood-2002-05-1516","article-title":"A critical role of placental growth factor in the induction of inflammation and edema formation","volume":"101","author":"Oura","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2003.09.002_BIB210","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1200\/JCO.2002.20.6.1446","article-title":"Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!","volume":"20","author":"Marx","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11912-001-0014-7","article-title":"Angiozyme: a novel angiogenesis inhibitor","volume":"3","author":"Weng","year":"2001","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbcan.2003.09.002_BIB212","first-page":"7002","article-title":"Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor","volume":"61","author":"Lu","year":"2001","journal-title":"Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X03000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X03000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T16:41:19Z","timestamp":1623602479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X03000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":212,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0304419X03000556"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2003.09.002","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}